NGGT002

· NGGT (Suzhou) Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NGGT002, covering 2024-11-14 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of NGGT002 in PKU Adult Subjects [EARLY_Phase 1]